# OnCo record nct07018050 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07018050/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07018050", "NCT07018050" ;
  schema:name "Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma"@en ;
  schema:description "A phase 2 trial of QLS32015, Pomalidomide, Dexamethasone in multiple myeloma, run by Qilu Pharmaceutical Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07018050/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07018050> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-09-12" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:drugs <https://onco.cc/drugs/qls32015/>, <https://onco.cc/drugs/pomalidomide/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/lenalidomide/> ;
  onco:companies <https://onco.cc/companies/qilu-pharmaceutical/> .